[Table/Fig-1]:
Test of significance for clinical and immunological characteristic of control and patients with periodontitis
| Characteristics | Control(n=25) Mean±SD (min-max) | Periodontitis (n=25) | |
|---|---|---|---|
| Before therapy | After therapy | ||
| AGE(yrs) | 34 (30-45) | 38(30-45) | 38(30-45) |
| GI | 0.04±0.12(0-0.42) | 1.84±.22 | 1.23±.47 |
| PI | 0.10±.14(0-0.54) | 1.78±.22 | 1.12±.22 |
| BOP | 3.80±2.53(0-7.80) | 89.26±10.57 | 35.47±19.84 |
| PPD | 1.86±0.27 | 3.32 ±0.50 | 2.67±.50 |
| CAL | 0 | 3.99±0.62 | 3.34±1.48 |
| IL-12 | 9.18±4.94(1.15-26.54)# | 9.79±5.70(0.38-22.31)*# | 15.93±12.09(5.76-65.76)*# |
*comparing the periodontitis patients (Wilcoxon Signed Rank Test p=.001, #comparing the control with periodontitis patients (Mann Whitney U Test), Control vs preoperative p=0.54 and control vs postoperative p<0.001